tyrphostin ag 1024 has been researched along with Local Neoplasm Recurrence in 1 studies
tyrphostin AG 1024: modulates radiosensitivity in human breast cancer cells; also an IGF1 receptor inhibitor
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deutsch, E | 1 |
| Maggiorella, L | 1 |
| Wen, B | 1 |
| Bonnet, ML | 1 |
| Khanfir, K | 1 |
| Frascogna, V | 1 |
| Turhan, AG | 1 |
| Bourhis, J | 1 |
1 other study available for tyrphostin ag 1024 and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Tyrosine kinase inhibitor AG1024 exerts antileukaemic effects on STI571-resistant Bcr-Abl expressing cells and decreases AKT phosphorylation.
Topics: Animals; Antineoplastic Agents; Benzamides; Cell Proliferation; DNA-Activated Protein Kinase; DNA-Bi | 2004 |